About this trial
This study employs a randomized controlled trial methodology to systematically evaluate the efficacy and safety of a modified acupotomy technique in the treatment of ankylosing spondylitis. Through ultrasound-guided localization, the operative sites are assessed to clarify the improvement effect of the modified acupotomy on disease activity in AS patients. The aim is to enhance the clinical outcomes of AS, provide evidence-based medical support for acupotomy treatment of AS, and improve the diagnosis and treatment standards for the condition.
Eligibility criteria
Qualifiers
Meeting the 1984 revised New York criteria or the 2009 Assessment of SpondyloArthritis International Society (ASAS) classification criteria for axial spondyloarthritis
Age 18-75 years
BASDAI ≥4
Signed informed consent form
Disqualifiers
Presence of autoimmune diseases other than the studied condition
Complete spinal ankylosis or spinal deformity
Pregnant or lactating women
Comorbid severe cardiovascular or cerebrovascular diseases, hepatic or renal failure, malignant tumors, or coagulation disorders
Trial design
Treatments tested in this trial
- Acupotomy
- Sham Acupotomy
Treatment groups
Sponsors and collaborators
China-Japan Friendship Hospital
Lead sponsor
The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine
Collaborator